Variations in Insulin Pump Use across Pediatric Endocrinology Centers in the U.S.
Background: The T1D Exchange Quality Improvement Collaborative (T1DX-QI) is a learning network of over forty US type 1 diabetes clinics.…
Background: The T1D Exchange Quality Improvement Collaborative (T1DX-QI) is a learning network of over forty US type 1 diabetes clinics.…
Background: The T1D Exchange Quality Improvement Collaborative (T1Dx-QI) is a learning network of over forty US type 1 diabetes clinics.…
The COVID-pandemic necessitated worldwide lockdowns in 2020, with restrictions on physical activity and changes in eating habits. We investigated temporal…
Introduction: The multi-center T1D Exchange QI Collaborative (T1DX-QI) is a learning health network sharing de-identified electronic medical record data for…
Background: Management of type 1 diabetes (T1D) involves achieving glycemic targets to avoid complications. However, despite advancements in diabetes technology…
Background: Insulin pump use is known to improve glycemic control in patients with type 1 diabetes (T1D), however, uptake of…
The utility of CGM to improve glycemic control and QoL is well established; however, real-world use of CGM varies among…
Background: The use of continuous subcutaneous insulin infusion (CSII), or insulin pump therapy, has been shown to improve glycemic control…
Background: The T1DX-QI was launched in 2016 with 10 participating centers and now has over 30 U.S. endocrinology centers that…
Objective: To evaluate the relationship of six diabetes self-management habits with Hemoglobin A1c (HbA1c) and by race and insurance. Methods:…